Global and United States Targeted Drug BRAF Inhibitors for NSCLC Market Report & Forecast 2023-2028

Report ID: 1869223 | Published Date: Dec 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Targeted Drug BRAF Inhibitors for NSCLC Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size for the Year 2017-2028
        1.2.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size for the Year 2017-2028
    1.3 Targeted Drug BRAF Inhibitors for NSCLC Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Targeted Drug BRAF Inhibitors for NSCLC in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Targeted Drug BRAF Inhibitors for NSCLC Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Targeted Drug BRAF Inhibitors for NSCLC Market Dynamics
        1.4.1 Targeted Drug BRAF Inhibitors for NSCLC Industry Trends
        1.4.2 Targeted Drug BRAF Inhibitors for NSCLC Market Drivers
        1.4.3 Targeted Drug BRAF Inhibitors for NSCLC Market Challenges
        1.4.4 Targeted Drug BRAF Inhibitors for NSCLC Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Targeted Drug BRAF Inhibitors for NSCLC by Type
    2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Segment by Type
        2.1.1 Dabrafenib
        2.1.2 Trametinib
        2.1.3 Lifirafenib
        2.1.4 Other
    2.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017, 2022 & 2028)
    2.3 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2028)
    2.4 United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017, 2022 & 2028)
    2.5 United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2028)
3 Targeted Drug BRAF Inhibitors for NSCLC by Application
    3.1 Targeted Drug BRAF Inhibitors for NSCLC Market Segment by Application
        3.1.1 Squamous Cell Carcinoma of NSCLC
        3.1.2 Adenocarcinoma of NSCLC
        3.1.3 Large Cell Carcinoma of NSCLC
    3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017, 2022 & 2028)
    3.3 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2028)
    3.4 United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017, 2022 & 2028)
    3.5 United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2028)
4 Global Targeted Drug BRAF Inhibitors for NSCLC Competitor Landscape by Company
    4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Company
        4.1.1 Top Global Targeted Drug BRAF Inhibitors for NSCLC Companies Ranked by Revenue (2021)
        4.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Player (2017-2022)
    4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Concentration Ratio (CR)
        4.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Targeted Drug BRAF Inhibitors for NSCLC in 2021
        4.2.3 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Targeted Drug BRAF Inhibitors for NSCLC Headquarters, Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Targeted Drug BRAF Inhibitors for NSCLC Headquarters and Area Served
        4.3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Companies Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Company
        4.5.1 Top Targeted Drug BRAF Inhibitors for NSCLC Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players (2020, 2021 & 2022)
5 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region
    5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2017-2028)
        5.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region: 2017-2022
        5.2.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.1.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.3.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.4.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 BeiGene
        7.1.1 BeiGene Company Details
        7.1.2 BeiGene Business Overview
        7.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction
        7.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
        7.1.5 BeiGene Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction
        7.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
        7.2.5 Novartis Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Targeted Drug BRAF Inhibitors for NSCLC Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Targeted Drug BRAF Inhibitors for NSCLC Market Trends
    Table 3. Targeted Drug BRAF Inhibitors for NSCLC Market Drivers
    Table 4. Targeted Drug BRAF Inhibitors for NSCLC Market Challenges
    Table 5. Targeted Drug BRAF Inhibitors for NSCLC Market Restraints
    Table 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Targeted Drug BRAF Inhibitors for NSCLC Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Share by Player, 2017-2022
    Table 13. Global Targeted Drug BRAF Inhibitors for NSCLC Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Targeted Drug BRAF Inhibitors for NSCLC by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2021)
    Table 15. Top Players of Targeted Drug BRAF Inhibitors for NSCLC in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Targeted Drug BRAF Inhibitors for NSCLC Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Targeted Drug BRAF Inhibitors for NSCLC Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Targeted Drug BRAF Inhibitors for NSCLC Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Targeted Drug BRAF Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Targeted Drug BRAF Inhibitors for NSCLC Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Targeted Drug BRAF Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Targeted Drug BRAF Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Targeted Drug BRAF Inhibitors for NSCLC Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. BeiGene Company Details
    Table 31. BeiGene Business Overview
    Table 32. BeiGene Targeted Drug BRAF Inhibitors for NSCLC Product
    Table 33. BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 34. BeiGene Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Targeted Drug BRAF Inhibitors for NSCLC Product
    Table 38. Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Research Programs/Design for This Report
    Table 41. Key Data Information from Secondary Sources
    Table 42. Key Data Information from Primary Sources
List of Figures
    Figure 1. Targeted Drug BRAF Inhibitors for NSCLC Product Picture
    Figure 2. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size 2017-2028 (US$ Million)
    Figure 4. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size 2017-2028 (US$ Million)
    Figure 6. United States Targeted Drug BRAF Inhibitors for NSCLC Market Share in Global 2017-2028
    Figure 7. Targeted Drug BRAF Inhibitors for NSCLC Report Years Considered
    Figure 8. Product Picture of Dabrafenib
    Figure 9. Product Picture of Trametinib
    Figure 10. Product Picture of Lifirafenib
    Figure 11. Product Picture of Other
    Figure 12. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type in 2022 & 2028
    Figure 13. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    Figure 15. United States Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type in 2022 & 2028
    Figure 16. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type (2017-2028)
    Figure 18. Product Picture of Squamous Cell Carcinoma of NSCLC
    Figure 19. Product Picture of Adenocarcinoma of NSCLC
    Figure 20. Product Picture of Large Cell Carcinoma of NSCLC
    Figure 21. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application in 2022 & 2028
    Figure 22. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    Figure 24. United States Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application in 2022 & 2028
    Figure 25. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application (2017-2028)
    Figure 27. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. BeiGene Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BeiGene
Novartis
Frequently Asked Questions
Targeted Drug BRAF Inhibitors for NSCLC report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Targeted Drug BRAF Inhibitors for NSCLC report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Targeted Drug BRAF Inhibitors for NSCLC report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Crizotinib

Crizotinib market is segmented by region (country), players, by Type and by Application. Players, ... Read More